NATALIE BARTLETT: Open Payments
NPI 1578213633 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 7 payments from 5 companies in 2025. Trend: 2023 $1,968 · 2024 $1,374 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $173 |
| ABBVIE INC. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: QULIPTA, LEQVIO, Kerendia, FUROSCIX.
Industry payments across CO — which companies pay providers there.
